Biggest News Aggregation in the World
📰 Linkedin News

Page 178 - Linkedin News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Linkedin. Real-time updates on events, politics, business and more.

Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA

SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that picankibart (R & D code: IBI112), a recombinant anti-interleukin 23p19 subunit (IL-23p19) antibody injection, has met all...
Yulin Shi Eli Lilly Adimab Incyte Innovent Biologics National Medical Product Administration Prnewswire Innovent Biologics Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cloud DX Will Report First Quarter 2024 Results on May 30, 2024. Company will also extend the closin

KITCHENER, ON / ACCESSWIRE / May 27, 2024 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), will post its Q1-2024 financial results after market close on Thursday May 30, 2024.At 2:00 pm EDT on May 31, 2024 CEO Robert Kaul will host an online Earnings Call to discuss financial results to March 31, 2024 as well as recent events of...
United States Robert Kaul Qualcomm Tricorder Simon Selkrig Teladoc Health Canada Regulation Services Provider

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science